Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma

Abstract excerpt

Malignant pleural mesothelioma (MPM) is a rare, but aggressive tumor with dismal prognosis. Platinum-based chemotherapy is regularly used as part of multimodality therapy. The expression of metallothioneins (MT) has been identified as a reason for cisplatin resistance, which often leads to early therapy failure or relapse. Thus, knockdown of MT expression may improve response to cisplatin treatment. The MT gene-...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Heavy Metal Exposure and Toxicity
• Share to Occupational and environmental lung diseases
• Share to Trace Elements in Health